SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-026388
Filing Date
2020-05-20
Accepted
2020-05-20 16:25:19
Documents
3
Period of Report
2020-05-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K oric-8k_20200520.htm 8-K 36718
2 EX-99.1 oric-ex991_10.htm EX-99.1 198786
3 GRAPHIC gspbsui5ds4z000001.jpg GRAPHIC 1896
  Complete submission text file 0001564590-20-026388.txt   239429
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39269 | Film No.: 20898437
SIC: 2834 Pharmaceutical Preparations